China NMPA Drug Inspection - Luoyang MuChun Pharmaceutical Co., Ltd. - Ginkgo biloba soft capsules
China NMPA drug inspection for Luoyang MuChun Pharmaceutical Co., Ltd. published October 15, 2015. Drug: Ginkgo biloba soft capsules. The State Food and Drug Administration (SFDA) published an announcement on October 15, 2015, detailing the results of ma
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Luoyang MuChun Pharmaceutical Co., Ltd. published October 15, 2015. Drug: Ginkgo biloba soft capsules. The State Food and Drug Administration (SFDA) published an announcement on October 15, 2015, detailing the results of ma
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox